Michael Blazar

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Michael Blazar is an author at Mercy Hospital specializing in malignant neoplasms, checkpoint inhibitor therapy, and neoadjuvant checkpoint inhibition.

Publications per year

2024–2024

Publications

A phase II/III study of peri-operative nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of the neoadjuvant pathologic complete response (pCR) rate (ECOG-ACRIN EA2174).

Jennifer R. Eads, Noah Graham, Michael K. Gibson et al. · Journal of Clinical Oncology · 2024 · 21 citations

Medicine, Oncology, Pharmacology +17

1–1 of 1